CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ALLO — Allogene Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in ALLO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,407,540
+$1,550,082 QoQ
Shares Held
1,396,533
+3.0% QoQ
Ownership
0.405%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,185,699,337 across 288 Biotechnology names. ALLO ranks #150 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in ALLO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,407,540 | 1,396,533 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,857,458 | 1,355,809 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,444,947 | 1,165,280 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,392,764 | 1,232,535 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,687,532 | 1,155,844 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $2,532,224 | 1,188,838 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,300,774 | 1,178,848 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,745,674 | 1,178,401 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,837,387 | 858,476 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,352,400 | 732,835 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,476,809 | 781,328 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,306,695 | 665,331 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,212,407 | 650,285 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,080,920 | 648,795 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,862,914 | 635,455 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,202,842 | 544,109 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,834,303 | 530,659 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $8,012,711 | 537,045 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $13,646,597 | 530,996 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $16,544,343 | 634,369 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $19,875,806 | 563,054 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $13,882,176 | 550,007 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $20,358,987 | 539,883 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $22,731,682 | 530,866 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $7,817,854 | 402,153 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||